Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in Asian patients with moderate to severe psoriasis: Findings from the phase 3 POETYK PSO-3 and PSO-4 trials
- Authors
- Foley, Peter; Zhang, Jianzhong; Imafuku, Shinichi; Ding, Yangfeng; Okubo, Yukari; Li, Hui; Tada, Yayoi; Li, Linfeng; Ohtsuki, Mamitaro; Pan, Weili; Lu, Yan; Hao, Cheng; Xian, Jiang; Ho, Ji-Chen; Guo, Shuping; Seo, Seong Jun; Napoli, Andrew; Chatterjee, Arkendu; Kisa, Renata M.; Banerjee, Subhashis; Morita, Akimichi
- Issue Date
- May-2023
- Publisher
- WILEY
- Citation
- AUSTRALASIAN JOURNAL OF DERMATOLOGY, v.64, pp 28 - 29
- Pages
- 2
- Journal Title
- AUSTRALASIAN JOURNAL OF DERMATOLOGY
- Volume
- 64
- Start Page
- 28
- End Page
- 29
- ISSN
- 0004-8380
1440-0960
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - ETC > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.